Navigation Links
Arthritis Drug May Fight Diabetes, Too
Date:3/15/2010

Study finds that salsalate helps control blood sugar levels

MONDAY, March 15 (HealthDay News) -- A generic drug widely prescribed for arthritis shows promise in treating type 2 diabetes, according to U.S. researchers.

They found that salsalate -- an atypical non-steroidal anti-inflammatory drug, chemically similar to aspirin but easier on the stomach -- helps control glucose levels.

The finding came from a three-month clinical trial of 108 people, 18 to 75 years old, who had type 2 diabetes. Those who took salsalate, the study found, had a 0.5 percent drop in levels of hemoglobin A1C, a measure of blood glucose levels. The decrease was in the range of several recently released diabetes treatments, according to the study, led by Joslin Diabetes Center researchers.

The findings are published online March 16 in Annals of Internal Medicine.

"These results are exciting," Dr. Allison Goldfine, director of clinical research at Joslin and an associate professor at Harvard Medical School, said in a news release from the center. "They indicate that salsalate may provide an effective, safe and inexpensive new avenue for diabetes treatment."

She stressed, however, that the findings were preliminary. "At this time we do not recommend patients use this medication for their diabetes treatment until further studies are completed," Goldfine said.

Goldfine added that salsalate also could help combat atherosclerosis (narrowing of the arteries). The study found that people who took the drug had lowered triglycerides and higher levels of adiponectin, a protein believed to help protect against heart problems.

More information

The U.S. National Institute of Diabetes and Digestive and Kidney Diseases has more about type 2 diabetes.



-- Robert Preidt



SOURCE: Joslin Diabetes Center, news release, March 15, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Using coxibs and NSAIDs to treat osteoarthritis
2. Biologic treatment for rheumatoid arthritis and the risk of cancer
3. Knee arthritis link to lung cancer
4. Genes Boost Risk for Rheumatoid Arthritis, Lupus
5. The genes involved in rheumatoid arthritis identified
6. Empowerment Program Gets Patients on the PATH to Managing the Physical and Emotional Effects of Psoriatic Arthritis
7. Genome Area Linked to Rheumatoid Arthritis
8. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
9. Meditation therapy for rheumatoid arthritis patients
10. Meditation May Help Rheumatoid Arthritis Sufferers
11. Researchers identify genes that increase rheumatoid arthritis risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... 18, 2017 , ... Mediaplanet today announces the launch of ... and highlighting the importance of proactive eye and ear health. The campaign focuses ... innovations in hearing aid technology. , In this issue, the American Speech-Language-Hearing ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, ... new charity drive to generate community support for efforts to educate the local population ... treatments for all types of cancer. , Each day in America, roughly 4,600 ...
(Date:8/18/2017)... ... August 18, 2017 , ... Radabaugh & ... assistance to communities in North-Central West Virginia, is embarking on a cooperative charity ... in the area. , The Chestnut Mountain Ranch (CMR) is a Christ-centered boarding ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... planning assistance that serves communities throughout southern Florida, is working to support the ... assets to children from low income families. , The Take Stock In Children ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... ... and financial planning firm that serves residential and commercial clients in the greater ... drive to raise community support for the fight against cancer. , Founded by ...
Breaking Medicine News(10 mins):
(Date:8/14/2017)... HACKENSACK, N.J. and PETACH TIKVAH, ... Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult ... for the second quarter ending June 30, 2017. ... advanced stages of preparing for our pivotal Phase 3 ... Chaim Lebovits , President and Chief Executive Officer ...
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... , Aug. 7, 2017 Zimmer Biomet Holdings, Inc. ... today announced that its Board of Directors has approved the ... third quarter of 2017. ... on or about October 27, 2017 to stockholders of record ... Future declarations of dividends are subject to approval of the ...
Breaking Medicine Technology: